Results and Discussion 4 [2] The pH profile of SpHex E314A was determined using pNP-GlcNAc as substrate by performing a depletion assay at ~0.1*Km (2.0 µM pNP-GlcNAc) at 37°C. The buffers contained 100 mM NaCl and 2 mg/mL BSA; pH 3-6.5: 25/25 mM citrate/phosphate; pH 7-8: 50 mM HEPES; pH 9-10: 50mM CHES. Release of pNP was detected at 405 nm (pH 6-10) and 348 nm (pH [3] [4] [5] [6] . A total of 2 or 3 runs were performed at each pH value: curves shown are representative. Exact pH values studied were: 3.3, 4.1,5.2, 6.2, 6.9, 7.9, and 8.7.
Thioglycoligation reactions: acceptor screening
Thioglycoligase reactions were performed at pH 7.0 in HEPES buffer (25 mM HEPES, 100 mM NaCl, 2 mg/mL BSA, 10 mM DTT). The respective thio sugar acceptor was dissolved in DMSO and diluted with buffer resulting in a 5 mM acceptor solution (5% DMSO). GlcNAc oxazoline (GlcNAc-oxa), which was synthesized following a procedure of Andre-Miral et al [3] , was used as donor for the initial screening, and pNP-GlcNAc or pNP-GalNAc was used for all further reactions on larger scales. The final assay concentrations were 30 mM donor, 5 mM thiol acceptor and 0.5 mg/mL SpHex E314A. All reactions for the acceptor screening were performed on a 100 µL scale at 37°C and monitored by TLC (5 EtOAc: 2 MeOH: 1 H2O) and ESI-MS. TLC spots were visualized via UV and subsequently stained with an anisaldehyde stain. The formation of the desired S-glycosidic bonds was further confirmed by TLC using a thiol-specific stain (1 mM DTNB in 0.1 M NaOAc), only staining compounds with free thiols. [4] All thio sugars (see Table 2 ) were synthesized according to literature procedures. [5] Product isolation and characterization Larger scale reactions were performed in a total volume of 4 mL, enabling sufficient synthesis of disaccharide products for NMR characterization. If the respective acceptor was not completely converted to product using the initial 30 mM donor, another aliquot of donor (pNP-GlcNAc or pNP-GalNAc, 2 mole equivalents) was added until all acceptor was consumed. After completion of the reaction the disaccharides were isolated using preparative HPLC, performed on an Agilent 1260 Infinity system equipped with a Agilent ZORBAX Eclipse XDB-C18 column (250 x 4.7 mm, 5 µm particle size), using a flow rate of 4 mL/min. The column was eluted with a linear gradient of water-acetonitrile (5-30% MeCN in 20 min). The product-containing fractions were pooled and dried on a SpeedVac concentrator. Pure reaction products were characterized by NMR on a Bruker AV-400 MHz spectrometer. The following retention times were observed for the isolated compounds: 10.0 min (1), 10.4 min (2), 10.8 min (3), 9.6 min (4), 5.7 min (GlcNAc-β-cysteine ethyl ester)
GlcNAc coupling to phenols
The efficiency of the ligase reaction of SpHex E314A was evaluated using different phenols of varying pKa values as model acceptors; 2,4-Dinitrophenol (pKa 4.1), 4-nitrophenol (pKa 7.2), 2-chlorophenol (pKa 8.6) and phenol (pKa 10.0) were chosen for this purpose. All reactions were performed at pH 8.0 in HEPES buffer (25 mM HEPES, 100 mM NaCl, 2 mg/mL BSA) and GlcNAc-oxa was used as activated donor substrate. Final concentrations in the assay were 5 mM GlcNAc-oxa, 0.5 mg/mL SpHex E314A and 20 mM of the respective phenol, except 2-chlorophenol which was used at 7 mM due to its limited solubility. Reactions were performed at 37°C and product formation was monitored by TLC (qualitative assay). The synthesis rate of SpHex E314A was determined using pNP as acceptor, following the decrease in absorption as a function of GlcNAc ligation to pNP. Reagent concentrations were chosen to be 2 mM GlcNAc-oxa donor and 40 µM pNP acceptor. Synthesis rates were determined at pH 7.0 (HEPES), pH 8.0 (HEPES), and pH 9.0 (CHES); molar extinction coefficients for the phenols were determined using identical buffers.
Peptide synthesis
Synuclein model peptides (pentamer) were synthesized covering the in vivo GlcNAcylation sites T 72 (AGTIA) and S 87 (VVSGV). [6, 7] Additionally, the same peptides were synthesized but with the GlcNAcylation sites replaced by cysteine (AGCIA / VVCGV), respectively, enabling S-GlcNAcylation by SpHex E314A. Automated peptide synthesis was performed using an Intavis MultiPep system. Fmoc rink amide MBHA resin was used throughout the syntheses. Peptides were synthesized under standard automated Fmoc protocols: Using DMF as solvent, deblock for 5 min, couple for 2 x 10 min. The following Fmoc amino acids (NovaBiochem) were employed: Fmoc-Ala-OH, Fmoc-Cys(Trt)-OH, Fmoc-Gly-OH, Fmoc-His(Trt)-OH, Fmoc-Ile-OH, Fmoc-Ser(tBu)-OH, Fmoc-Thr(tBu)-OH, Fmoc-Val-OH. Excess amino acids (4 eq.), coupling reagent (HBTU, 4 eq.) and acidic modifier (HOBt, 1 eq.) was employed for each cycle. NMM (4 eq.) was used as base in the coupling step, and deblock solution was prepared as a mixture of DMF/piperidine (4:2, v/v). After the final deprotection, the cleavage of the peptides from the resin was performed periodically by adding a solution of TFA/phenol/water/TIPS (88:5:5:2) over 1 h. Crude peptides were precipitated from the TFA solution by 100-fold dilution into ice cold diethyl ether. The precipitate was washed 3 times with ice cold diethyl ether and dried. Crude peptides were dissolved in 50% MeCN and the filtered solution was subjected to HPLC purification using the same equipment and column as mentioned before. A linear gradient was applied (5-95% MeCN, 0.1% TFA, over 15 min) and the respective product fractions were confirmed by ESI-MS.
Thioglycoligation of GlcNAc to synuclein model peptides and a Tau S400C variant
The thioglycoligation to peptides and Tau (244-441) S400C was performed using a similar approach to that described for the sugar acceptor screen, again using HEPES buffer. Tau (244-441) wt contains 2 native cysteines C301 and C322 which were mutated to serines; thus the version of the tau protein (Tau S400C) used was the triple mutant C301S C322S T400C. GlcNAcylation of the synuclein cysteine peptide variants was performed in the presence of 10 mM DTT, preventing disulfide formation, 10 mM pNP-GlcNAc and 1 mg/mL of the respective peptide. Reactions were initiated by the addition of SpHex E314A (0.1 mg/mL final concentration). For the S-GlcNAcylation of Tau (244-441) S400C all experiments were performed in bicarbonate buffer (20 mM, pH 7.0) using final concentrations of 160 µM Tau S400C and 6.5 mM pNP-GlcNAc. All reactions were incubated at 37°C for 3 h prior to product analysis. Mass spectrometry The synuclein peptide reactions were analyzed on a Bruker Autoflex MALDI TOF MS using a Super DHB matrix (dissolved in 0.1% TFA), whereby 1 µL of a 1:1 mixture of matrix and reaction solution was spotted and dried on a MALDI sample plate. HPLC analyses of the reactions were performed on the above-mentioned instrument and column using the following gradient: 0.3 min 95% H2O, 3-5 min to 75% H2O, 5-20 min to 5% H2O. Reaction yields were determined by HPLC, comparing the integrals of S-GlcNAcylated peptides to those of the peptide starting material.
S-GlcNAcylation reactions with Tau (244-441) S400C were analyzed on the intact protein by ESI-TOF MS on a Waters Xevo G2-S qTOF MS. Samples were diluted in 0.1% formic acid resulting a final concentration of 3 µg/mL and subjected to a Waters nanoACQUITY UPLC, equipped with a Zorbax 300SB-C8 column (Agilent): aliquots of 5 µL were subjected to MS analysis. Data were analyzed with a Waters MassLynx V4.1 mass spectrometer and a MaxEnt1 algorithm was used for deconvolution of the protein mass from the multiply charged species.
Titration of free thiols on tau
The selective GlcNAcylation of Cys 400 of Tau S400C was confirmed by titrating the remaining free thiols of Tau S400C, using a modified version of the method of Riener et al. [8] GlcNAcylation experiments were performed as described above. Afterwards, tau was purified from DTT and other small molecule impurities using an Amicon Ultra centrifugal filters with a MWCO of 3 kDa (Merck) and repeatedly washing with 0.1 M NH4HCO3. The retentate was freeze-dried, afterwards dissolved in 100 µL ddH2O and the protein concentration was determined using the Bradford reagent (Thermo scientific), using 10µL of sample. The samples were freeze-dried again, dissolved in 100 µL sodium phosphate buffer (100 mM NaH2PO4, 0.2 mM EDTA, pH 7.0) containing 6 M guanidinium-Cl and incubated at rt for 10 min. The 100 µL were split in aliquots of 50, 30, 10 and 5 µL, respectively, and diluted to a final volume of 100 µL using the same buffer. Two µL of the thiol titration reagent was added, consisting of phosphate buffer, 6 M guanidinium-Cl and 40 mM DTNB; the mixture was incubated in a Synergy H1 plate reader (BioTek) at 25°C and release of 2-nitro-5-thiobenzoate was monitored at 412 nm. Negative controls were measured mixing the mentioned buffer with 2 µL titration reagent monitoring eventual spontaneous hydrolysis of the DTNB reagent. The maximal absorption values of the different dilutions were plotted against the protein concentration. The slope of the linear regression is a measure of the free thiols present content and the values of the slopes were corrected with the protein concentration (=correction factor) to take into account varying protein concentrations due to different protein recovery from the Amicon purifications. The yield of S-GlcNAcylation was calculated directly comparing the corrected slopes of the SpHex GlcNAcylated tau to untreated tau. Due to the reduced shelf life of the DTNB titration reagent, experiments with BSA (bearing one free thiol) were conducted regularly to validate the method.
Figures
Scheme S1. (a) Wild type "Koshland-type" glycoside hydrolase mechanism, (b) nucleophile mutant acting as a glycosynthase using an α-glycosyl fluoride as donor, (c) acid/base mutant acting as a thioglycoligase using a β-donor with a good leaving group (LG). Figure S1 . pH profile of SpHex E314A using pNP-GlcNAc as substrate. The enzyme rapidly loses activity at pH 3. Figure S2 . ESI-MS analyses confirming the thioglycoligation products described in Figure S1 . The thiosugar acceptor is shown on top of each product mass spectrum. Figure S3 . TLC screen of a thioglycoligation screen using SpHex E314A and a range of thiosugar acceptors. Structures on the top of each depict the thiosugar acceptor. "SpHex E314A" refers to the thioglycoligation reaction: the "Blank reaction" was performed in the absence of the enzyme. TLC spots were visualized by UV, the ligation donor GlcNAc-oxa is not UV-active and thus not visualized within this figure. The TLC´s shown were performed after ~15 min reaction time and thus do not depict full conversion of the thiosugar acceptor. Mobile phase: EtOAc:MeOH:H2O (7:5:2) Figure S4 . TLC analysis of selected thioglycoligations, visualized with a p-anisaldehyde stain (left) and a DTNB stain (right) selectively staining free thiols; thioglycoligations using 4-S-GlcNAc pNP (A), 6-S-Glc pNP (B) and cysteine ethyl ester (C) as acceptors. "SpHex E314A" refers to the thioglycoligation reaction and pNP-GlcNAc was the used donor. Cysteine (ethyl ester) was the thioacceptor. 
